GPR30 predicts poor survival for ovarian cancer.
Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER.
Smith HO, et al. Among authors: lee sj.
Gynecol Oncol. 2009 Sep;114(3):465-71. doi: 10.1016/j.ygyno.2009.05.015. Epub 2009 Jun 6.
Gynecol Oncol. 2009.
PMID: 19501895
Free PMC article.